Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Altman, Neuralink

Digest more
 · 13h
Sam Altman Despises Elon Musk. Now He Is Going After His Companies
Over the last year, the feud between Silicon Valley heavyweights Sam Altman and Elon Musk has devolved into personal attacks, social media swipes, and lawsuits. Musk calls his foe

Continue reading

 · 3d
OpenAI, cofounder Sam Altman to take on Neuralink with new startup
 · 1d · on MSN
Sam Altman’s rival to Neuralink reportedly eying gene therapy technology
Daily Jang
3d

Sam Altman to invest in Merge Labs in bid to outdo Elon Musk’s Neuralink

In a strategic move, OpenAI CEO Sam Altman is reportedly planning to invest in a brain implant startup, called Merge Labs, ...
4d

Did Sam Altman Accidentally Admit That The AI Bubble Is Here?

A recent CNBC interview with the OpenAI CEO shows that tech leaders are changing how they judge AI models.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Trending now

To meet Trump in Wash.
Trump: No deal reached
WV governor to deploy troops
'General Hospital' star dies
To remove DC police chief
Greg Iles dies at 65
Erin becomes a Category 5
Man fleeing ICE raid killed
New Orleans mayor indicted
'House of Cards' actor dies
Power banks recalled
Rules out presidential bid
Sean Kingston sentenced
Jeff Bezos' mother dies
Del Records CEO sentenced
To visit Mexico in September
Flight attendants strike
Flu vaccine at home
Denmark train accident
Ryazan plant fire kills 11
Reds place Burns on IL
Suspect charged in PR
Trump shifts to peace deal
Halts Gaza visitor visas
Court okays hospital run
California man rescued
DOJ sues California
NCAA fines Michigan
Calls second special session
Sickle cell drug fails
US consumer sentiment falls
Court: CFPB cuts can resume
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy